Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rasagiline (azilect) (1 trial)
Amyotrophic Lateral Sclerosis (Phase 2)
Motor Neuron Disease (Phase 2)
Sclerosis (Phase 2)
Trials (1 total)
Trial APIs (1 total)